Fig. 3From: TGFβ1 pathway components in breast cancer tissue from aggressive subtypes correlate with better prognostic parameters in ER-positive and p53-negative cancersCorrelation between TGFβ1, TGFβRII and p-SMAD2/3 in breast cancer tissue. a Distribution of data regarding TGFβ1, TGFβRII and p-SMAD2/3 immunostaining in BC tissue. Lines connect data from the same patients. b Correlation between TGFβ1 and TGFβRII, TGFβ1 and p-SMAD2/3 and between TGFβRII and p-SMAD2/3. Tau-b correlation coefficient and p-values are shown within each graph. LB: Luminal-B-HER2+ subtype. HER2: HER2-enriched subtype. TN: triple-negative subtypeBack to article page